Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of March 2026, with a report date of March 17, 2026. The document serves as a transaction notification regarding a purchase of company securities by a Person Discharging Managerial Responsibilities (PDMR) rather than a financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to a specific insider transaction and does not contain consolidated financial statements.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only recorded activity is the acquisition of American Depositary Shares (ADS) by Maya Martinez-Davis, President of GSK US, on March 13, 2026.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a routine disclosure of an executive's participation in the GSK Executive Supplemental Savings Plan.
Important Facts for Investors
- Transaction Type: Acquisition of notional ADS within an executive savings plan.
- Executive Involved: Maya Martinez-Davis, President, US.
- Transaction Date: March 13, 2026.
- Volume: 129.152 ADS.
- Price: $53.3900 per ADS.
- Exchange: New York Stock Exchange (XNYS).